ROCHE

Esbriet-pirfenex

"Esbriet" contains the Drug / Molecule called “Pirfenidone”. Esbriet exhibits both anti-inflammatory and antifibrotic effects. Esbriet reduces fibroblast proliferation inhibits TGF-β stimulated collagen production and reduces the production of fibrogenic mediators such as TGF-β. Esbriet also been shown to reduce production of inflammatory mediators such as TNF-α and IL-1β in both cultured cells and isolated human peripheral blood mononuclear cells.

“Pirfenex” is generic version of “Esbrite” and both contain same Drug / Molecule “Pirfenidone”.

Details
Specification

Indication

Esbriet is used to treat mild to moderate forms of a certain lung disease called Idiopathic pulmonary fifrosis (IPF).

Note

Precaution

Esbriet is a prescription drug and should be used under proper medical guidance and advice.

Updated On Nov 02, 2019 by Admin

Strength

267 mg

Packing

270 Capsules (Bottle)

Storage

Store at room Temperature (25 C).

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Esbriet-pirfenex also available as

CIPLA LTD. (INDIA)

Pirfenex

"Pirfenex" contains the Drug / Molecule “Pirfenidone”. Pirfenex exhibits both anti-inflammatory and antifibrotic effects. Pirfenidone reduces fibroblast proliferation inhibits TGF-β stimulated collagen production and reduces the production of fibrogenic mediators such as TGF-β.Pirfenidone has also been shown to reduce production of inflammatory mediators such as TNF-α and IL-1β in both cultured cells and isolated human peripheral blood.